These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 12678335)

  • 1. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
    Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
    Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
    Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
    Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF
    Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
    Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
    J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease.
    Weidlich S; Bulau AM; Schwerd T; Althans J; Kappler R; Koletzko S; Mayr D; Bufler P
    J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):e18-26. PubMed ID: 24732025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
    Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease.
    Vainer B; Nielsen OH; Hendel J; Horn T; Kirman I
    Cytokine; 2000 Oct; 12(10):1531-6. PubMed ID: 11023669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
    Caprioli F; Bosè F; Rossi RL; Petti L; Viganò C; Ciafardini C; Raeli L; Basilisco G; Ferrero S; Pagani M; Conte D; Altomare G; Monteleone G; Abrignani S; Reali E
    Inflamm Bowel Dis; 2013; 19(4):729-39. PubMed ID: 23448791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease.
    Nishiwaki T; Ina K; Goto H; Watanabe O; Tsuzuki T; Furuta R; Ando T; Hibi K; Kusugami K
    J Gastroenterol; 2005 Feb; 40(2):128-36. PubMed ID: 15770395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
    D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
    J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive IL-18 expression is up-regulated in Crohn's disease.
    Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
    J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.